Services
As your development partner, we will provide your company with pharmaceutical development services that are responsive, personal, efficient, and strategically sound. Using our established network of expert consultants (e.g., experts in the fields of toxicology, clinical development, pharmacokinetics, pharmaceutics, analytical chemistry, etc.) we are able to offer your company a large, well-established organization of specialists with expertise in all areas of drug development.
Developing and implementing efficient scientific regulatory strategies early to reduce the overall product development time and research investments, while maximizing the market years and thereby increasing the return on research investment.
» Reduce the cycle time
A Risk Evaluation and Mitigation Strategy (REMS) is a recent and emerging regulatory requirement whereby the FDA expects pharmaceutical and biotech companies to monitor, submit plans, and proactively manage safety risks as part of NDA submission and life-cycle management.
» Learn how Beckloff associates can help
Beckloff Associates understands the
Electronic Common Technical Document (eCTD), and is ready to help you unlock the full lifecycle value of electronic content and submission management.
» Preparation and submission of eCTDs and more
Our partnering model involves designating one or more of our highly experienced technical consultants as a dedicated resource to your organization.
» How does it work?
Beckloff Associates, Inc., can add value to your regulatory submissions by understanding and interpreting the strategic and scientific aspects of your development program.
» Learn more about the Beckloff Advantage